{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:53:12Z","timestamp":1791348792975,"version":"4.3.1"},"reference-count":47,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GATA1 is mutated in patients with 2 different disorders. First, individuals with a GATA1 mutation that blocks the interaction between GATA-1 and its cofactor Friend of GATA-1 (FOG-1) suffer from dyserythropoietic anemia and thrombocytopenia. Second, children with Down syndrome who develop acute megakaryoblastic leukemia harbor mutations in GATA1 that lead to the exclusive expression of a shorter isoform named GATA-1s. To determine the effect of these patient-specific mutations on GATA-1 function, we first compared the gene expression profile between wild-type and GATA-1\u2013deficient megakaryocytes. Next, we introduced either GATA-1s or a FOG-binding mutant (V205G) into GATA-1\u2013deficient megakaryocytes and assessed the effect on differentiation and gene expression. Whereas GATA-1\u2013deficient megakaryocytes failed to undergo terminal differentiation and proliferated excessively in vitro, GATA-1s\u2013expressing cells displayed proplatelet formation and other features of terminal maturation, but continued to proliferate aberrantly. In contrast, megakaryocytes that expressed V205G GATA-1 exhibited reduced proliferation, but failed to undergo maturation. Examination of the expression of megakaryocyte-specific genes in the various rescued cells correlated with the observed phenotypic differences. These studies show that GATA-1 is required for both normal regulation of proliferation and terminal maturation of megakaryocytes, and further, that these functions can be uncoupled by mutations in GATA1.<\/jats:p>","DOI":"10.1182\/blood-2005-02-0551","type":"journal-article","created":{"date-parts":[[2005,4,29]],"date-time":"2005-04-29T00:34:27Z","timestamp":1114734867000},"page":"1223-1231","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":105,"title":["Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development"],"prefix":"10.1182","volume":"106","author":[{"given":"Andrew G.","family":"Muntean","sequence":"first","affiliation":[{"name":"From the Ben May Institute for Cancer Research, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Crispino","sequence":"additional","affiliation":[{"name":"From the Ben May Institute for Cancer Research, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218230991400_REF1","doi-asserted-by":"crossref","unstructured":"Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol.2005;16: 137-147.","DOI":"10.1016\/j.semcdb.2004.11.002"},{"key":"2020021218230991400_REF2","doi-asserted-by":"crossref","unstructured":"McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H, Orkin SH. A \u201cknockdown\u201dmutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A.1997;94: 6781-6785.","DOI":"10.1073\/pnas.94.13.6781"},{"key":"2020021218230991400_REF3","doi-asserted-by":"crossref","unstructured":"Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J1997;16: 3965-3973.","DOI":"10.1093\/emboj\/16.13.3965"},{"key":"2020021218230991400_REF4","doi-asserted-by":"crossref","unstructured":"Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood. 1999;93: 2867-2875.","DOI":"10.1182\/blood.V93.9.2867"},{"key":"2020021218230991400_REF5","doi-asserted-by":"crossref","unstructured":"Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet.2000;24: 266-270.","DOI":"10.1038\/73480"},{"key":"2020021218230991400_REF6","doi-asserted-by":"crossref","unstructured":"Chang AN, Cantor AB, Fujiwara Y, et al. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci U S A.2002;99: 9237-9242.","DOI":"10.1073\/pnas.142302099"},{"key":"2020021218230991400_REF7","doi-asserted-by":"crossref","unstructured":"Shimizu R, Ohneda K, Engel JD, Trainor CD, Yamamoto M. Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood.2004;103: 2560-2567.","DOI":"10.1182\/blood-2003-07-2514"},{"key":"2020021218230991400_REF8","doi-asserted-by":"crossref","unstructured":"Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood.2001;98: 2681-2688.","DOI":"10.1182\/blood.V98.9.2681"},{"key":"2020021218230991400_REF9","doi-asserted-by":"crossref","unstructured":"Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet.2002;32: 148-152.","DOI":"10.1038\/ng955"},{"key":"2020021218230991400_REF10","doi-asserted-by":"crossref","unstructured":"Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood.2003;101: 4298-4300.","DOI":"10.1182\/blood-2002-12-3904"},{"key":"2020021218230991400_REF11","doi-asserted-by":"crossref","unstructured":"Weiss MJ, Yu C, Orkin SH. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol.1997;17: 1642-1651.","DOI":"10.1128\/MCB.17.3.1642"},{"key":"2020021218230991400_REF12","doi-asserted-by":"crossref","unstructured":"Visvader J, Adams JM. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood.1993;82: 1493-1501.","DOI":"10.1182\/blood.V82.5.1493.1493"},{"key":"2020021218230991400_REF13","doi-asserted-by":"crossref","unstructured":"Shimizu R, Takahashi S, Ohneda K, Engel JD, Yamamoto M. In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J.2001;20: 5250-5260.","DOI":"10.1093\/emboj\/20.18.5250"},{"key":"2020021218230991400_REF14","doi-asserted-by":"crossref","unstructured":"Kolbus A, Pilat S, Husak Z, et al. Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med.2002;196: 1347-1353.","DOI":"10.1084\/jem.20020562"},{"key":"2020021218230991400_REF15","doi-asserted-by":"crossref","unstructured":"Geddis AE, Kaushansky K. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood.2004;104: 1017-1024.","DOI":"10.1182\/blood-2004-02-0419"},{"key":"2020021218230991400_REF16","doi-asserted-by":"crossref","unstructured":"Bahnson AB, Dunigan JT, Baysal BE, et al. Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods.1995;54: 131-143.","DOI":"10.1016\/0166-0934(95)00035-S"},{"key":"2020021218230991400_REF17","doi-asserted-by":"crossref","unstructured":"Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol.1993;13: 668-676.","DOI":"10.1128\/MCB.13.1.668"},{"key":"2020021218230991400_","doi-asserted-by":"crossref","unstructured":"Martin F, Prandini MH, Thevenon D, Marguerie G, Uzan G. The transcription factor GATA-1 regulates the promoter activity of the platelet glycoprotein IIb gene. J Biol Chem.1993;268: 21606-21612.","DOI":"10.1016\/S0021-9258(20)80584-5"},{"key":"2020021218230991400_REF19","doi-asserted-by":"crossref","unstructured":"Block KL, Poncz M. Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression. Stem Cells.1995;13: 135-145.","DOI":"10.1002\/stem.5530130205"},{"key":"2020021218230991400_REF20","doi-asserted-by":"crossref","unstructured":"Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene.2002; 21: 3359-3367.","DOI":"10.1038\/sj.onc.1205323"},{"key":"2020021218230991400_REF21","doi-asserted-by":"crossref","unstructured":"Halupa A, Bailey ML, Huang K, Iscove NN, Levy DE, Barber DL. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood.2005;105: 552-561.","DOI":"10.1182\/blood-2003-09-3237"},{"key":"2020021218230991400_REF22","doi-asserted-by":"crossref","unstructured":"Jenkins BJ, Quilici C, Roberts AW, Grail D, Dunn AR, Ernst M. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling. Exp Hematol.2002;30: 1248-1256.","DOI":"10.1016\/S0301-472X(02)00929-3"},{"key":"2020021218230991400_REF23","doi-asserted-by":"crossref","unstructured":"Lacabaratz-Porret C, Launay S, Corvazier E, Bredoux R, Papp B, Enouf J. Biogenesis of endoplasmic reticulum proteins involved in Ca2+ signalling during megakaryocytic differentiation: an in vitro study. Biochem J.2000;350(pt 3): 723-734.","DOI":"10.1042\/bj3500723"},{"key":"2020021218230991400_REF24","doi-asserted-by":"crossref","unstructured":"Martinez-Pinna J, Tolhurst G, Gurung IS, Vandenberg JI, Mahaut-Smith MP. Sensitivity limits for voltage control of P2Y receptor-evoked Ca2+ mobilization in the rat megakaryocyte. J Physiol.2004;555: 61-70.","DOI":"10.1113\/jphysiol.2003.056846"},{"key":"2020021218230991400_REF25","doi-asserted-by":"crossref","unstructured":"Wolf BB, Goldstein JC, Stennicke HR, et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood.1999;94: 1683-1692.","DOI":"10.1182\/blood.V94.5.1683"},{"key":"2020021218230991400_REF26","doi-asserted-by":"crossref","unstructured":"Kerrigan SW, Gaur M, Murphy RP, Shattil SJ, Leavitt AD. Caspase-12: a developmental link between G-protein-coupled receptors and integrin alphaIIbbeta3 activation. Blood.2004;104: 1327-1334.","DOI":"10.1182\/blood-2003-10-3633"},{"key":"2020021218230991400_REF27","doi-asserted-by":"crossref","unstructured":"Lecine P, Shivdasani RA. Cellular and molecular biology of megakaryocyte differentiation in the absence of lineage-restricted transcription factors. Stem Cells.1998;16(suppl 2): 91-95.","DOI":"10.1002\/stem.5530160712"},{"key":"2020021218230991400_REF28","doi-asserted-by":"crossref","unstructured":"Italiano JE Jr, Bergmeier W, Tiwari S, et al. Mechanisms and implications of platelet discoid shape. Blood.2003;101: 4789-4796.","DOI":"10.1182\/blood-2002-11-3491"},{"key":"2020021218230991400_REF29","doi-asserted-by":"crossref","unstructured":"Hung HL, Pollak ES, Kudaravalli RD, Arruda V, Chu K, High KA. Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors. Blood.2001;97: 946-951.","DOI":"10.1182\/blood.V97.4.946"},{"key":"2020021218230991400_REF30","doi-asserted-by":"crossref","unstructured":"Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev.1994;8: 1184-1197.","DOI":"10.1101\/gad.8.10.1184"},{"key":"2020021218230991400_REF31","doi-asserted-by":"crossref","unstructured":"Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A.2003;100: 8811-8816.","DOI":"10.1073\/pnas.1432147100"},{"key":"2020021218230991400_REF32","doi-asserted-by":"crossref","unstructured":"Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J.2002; 21: 5225-5234.","DOI":"10.1093\/emboj\/cdf527"},{"key":"2020021218230991400_REF33","doi-asserted-by":"crossref","unstructured":"Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol.2002;190: 7-20.","DOI":"10.1002\/jcp.10035"},{"key":"2020021218230991400_REF34","doi-asserted-by":"crossref","unstructured":"Vilaboa N, Bermejo R, Martinez P, Bornstein R, Cales C. A novel E2 box-GATA element modulates Cdc6 transcription during human cells polyploidization. Nucleic Acids Res.2004;32: 6454-6467.","DOI":"10.1093\/nar\/gkh981"},{"key":"2020021218230991400_REF35","doi-asserted-by":"crossref","unstructured":"Rylski M, Welch JJ, Chen YY, et al. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol.2003;23: 5031-5042.","DOI":"10.1128\/MCB.23.14.5031-5042.2003"},{"key":"2020021218230991400_REF36","doi-asserted-by":"crossref","unstructured":"Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood.1999;94: 87-96.","DOI":"10.1182\/blood.V94.1.87.413k41_87_96"},{"key":"2020021218230991400_REF37","doi-asserted-by":"crossref","unstructured":"Bartunek P, Kralova J, Blendinger G, Dvorak M, Zenke M. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene.2003;22: 1927-1935.","DOI":"10.1038\/sj.onc.1206281"},{"key":"2020021218230991400_REF38","doi-asserted-by":"crossref","unstructured":"Crispino JD, Lodish MB, MacKay JP, Orkin SH. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. Mol Cell.1999;3: 219-228.","DOI":"10.1016\/S1097-2765(00)80312-3"},{"key":"2020021218230991400_REF39","doi-asserted-by":"crossref","unstructured":"Letting DL, Chen YY, Rakowski C, Reedy S, Blobel GA. Context-dependent regulation of GATA-1 by friend of GATA-1. Proc Natl Acad Sci U S A.2004;101: 476-481.","DOI":"10.1073\/pnas.0306315101"},{"key":"2020021218230991400_REF40","doi-asserted-by":"crossref","unstructured":"Pal S, Cantor AB, Johnson KD, et al. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc Natl Acad Sci U S A.2004;101: 980-985.","DOI":"10.1073\/pnas.0307612100"},{"key":"2020021218230991400_REF41","doi-asserted-by":"crossref","unstructured":"Ikonomi P, Rivera CE, Riordan M, Washington G, Schechter AN, Noguchi CT. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp Hematol.2000;28: 1423-1431.","DOI":"10.1016\/S0301-472X(00)00553-1"},{"key":"2020021218230991400_REF42","doi-asserted-by":"crossref","unstructured":"Visvader JE, Crossley M, Hill J, Orkin SH, Adams JM. The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol Cell Biol.1995;15: 634-641.","DOI":"10.1128\/MCB.15.2.634"},{"key":"2020021218230991400_REF43","unstructured":"Choe KS, Radparvar F, Matushansky I, Rekhtman N, Han X, Skoultchi AI. Reversal of tumorigenicity and the block to differentiation in erythro-leukemia cells by GATA-1. Cancer Res.2003;63: 6363-6369."},{"key":"2020021218230991400_REF44","doi-asserted-by":"crossref","unstructured":"Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood.2004;103: 399-406.","DOI":"10.1182\/blood-2003-05-1556"},{"key":"2020021218230991400_REF45","doi-asserted-by":"crossref","unstructured":"Schwieger M, Lohler J, Fischer M, Herwig U, Tenen DG, Stocking C. A dominant-negative mutant of C\/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse. Blood.2004;103: 2744-2752.","DOI":"10.1182\/blood-2003-07-2280"},{"key":"2020021218230991400_REF46","doi-asserted-by":"crossref","unstructured":"Toki T, Katsuoka F, Kanezaki R, et al. Transgenic expression of Bach1 transcription factor results in megakaryocytic impairment. Blood.2005;105: 3100-3108.","DOI":"10.1182\/blood-2004-07-2826"},{"key":"2020021218230991400_REF47","doi-asserted-by":"crossref","unstructured":"Li C, Wong W. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A.2001;98: 31-36.","DOI":"10.1073\/pnas.98.1.31"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1223\/1712457\/zh801605001223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/4\/1223\/1712457\/zh801605001223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T04:57:03Z","timestamp":1625893023000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/4\/1223\/21555\/Differential-requirements-for-the-activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,15]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-02-0551","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,15]]}}}